Chong Kun Dang Pharmaceutical Corp.

₩63,000As of Sun 8 Nov 2026, 12:00 UTC
KRX:185750Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 0.87%
Div yield 0.79%
ROE 8.23%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.21
PE TTM 10.54
TSR TTM (23.47%)
Mkt cap ₩830.1B
ROIC 6.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩79,134
25.61%
(66.64%)
Hold 0|9|1|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
694.23
706.36
730.04
704.97
(3.16%)
2.46%
9.55%
(1.48%)
Revenue₩B
59.02
61.14
61.10
61.91
3.25%
6.12%
9.02%
8.21%
Peers (US$612.0M)
Cap (US$)
PE
529.1M
5.939x
499.0M
3.720x
Capital
TTM
5Y
10Y
Leveragex
1.962
(0.056)
(0.040)
EBIT/Intx
0.568
0.109
0.107
Own earn%
(50.26)
27.17
20.81
Sh yield%
27.58
40.18
36.53
Owners
Insiders/Inst%
10.88
31.81
Short interest%
5.78
SBC / revenue%
4.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–10
$1 testx
−0.1
Incr. ROIC%
0